Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Squalene in Acute Myocardial Infarction
IRCT20221021056258N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of squalene in myocardial infarction (MI) and heart failure (HF), sponsored by Mashhad University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
squalene
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on IRCT20221021056258N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221021056258N1.